Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression

European Journal of Cancer

Volumn 32, Issue 3, 1996, Pages 396-397

  Oliver, R T D ^a   Tobias, J ^b   Gallagher, C ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; LENTINAN;

ADJUVANT THERAPY; BREAST CANCER; FEMALE; HORMONAL THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INJURY; PRIORITY JOURNAL; SHORT SURVEY; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DISEASE PROGRESSION; GROWTH SUBSTANCES; HUMANS; IMMUNOSUPPRESSION; RECURRENCE;

EID: 0029990261     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00589-7     Document Type: Article

References (20)

1. Peeters P, Verbeek A, Staatman H, et al. Evaluation of overdiagnosis of breast cancer in screening with mammography, results of the Nijmegan programme. Int J Epidemiol 1989, 18, 295-299.
2. Joynes F, Rous P. On the cause of localisation of secondary tumour at points of injury. J Exp Med 1914, 20, 404-412.
3. Alexander P, Murphy P, Skipper D. Preferential growth of blood borne cancer cells at site of trauma - a growth promoting role of macrophages. Adv Exp Med Biol 1988, 233, 245-251.
4. Oliver RTD, Nouri AME. T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy. Cancer Surv 1991, 13, 173.
5. Stjernswald J, Jondal M, Vanky F, et al. Irradiation induced T cell lymphopenia after breast cancer radiation treatment. Lancet 1972, 1, 1352-1356.
6. de Ruysscher D, et al. Irradiation induced T cell lymphopenia after breast cancer treatment. Eur J Cancer 1992, 28A, 1729-34.
7. Houghton J, Baum M, Haybittle J. Role of radiotherapy following total mastectomy in patients with early breast cancer. World J Surg 1994, 18, 117-122.
8. van Leeuwen FE, Stiggelbout AM, Vandenbeltdusebout AW, et al. Second tumours after radiation treatment of testicular germ-cell tumours. J Clin Oncol 1993, 11, 2286-2287.
9. Fair WR, Israeli RS, Wang Y, et al. Neoadjuvant androgen deprivation therapy prior to radical prostatectomy decreases PSM RT-PSR detected micrometastases. J Urol 1995, 150 (suppl) Proc AUA abstr.
10. Fentiman I, Gregory W. Influence of surgery and menstrual cycle on breast cancer survival. Cancer Surveys 1994, 18, 154.
11. Fentiman IS, Gregory WM, Richards M. Effect of menstrual phase on surgical treatment of breast cancer. Lancet 1994, 344, 402.
12. Badwe RA, Wang DY, Gregory WM, Fentiman IS, et al. Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur J Cancer 1994, 30A, 445-448.
13. Early Breast Cancer Trialists Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992, 339, 1-15.
14. Scottish/ICRF Breast Unit. Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: the Scottish trial. Lancet 1993, 341, 1293-1298.
15. Gazet J, Markopoulos C, Ford H. Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer. Lancet 1988, 1, 679-681.
16. Jones AL, Smith IE, O'Brien MER, et al. Phase II study of continuous infusional 5-FU with epirubicin and cisplatin (infusional ECF) in patients with metastatic and locally advanced breast cancer: a very active new regimen. J Clin Oncol 1994, 12, 1259-1265.
17. Grossman CJ. Interactions between the gonadal-steroids and the immune system. Science 1985, 227, 257-261.
18. Oliver RTD, Joseph JV, Gallagher CJ. Castration-induced lymphocytosis in prostate cancer: possible evidence for gonad/thymus endocrine interaction in man. Urol Int 1995, 54, 226.
19. Kosaka A, Hattori Y, Imaizumi A, Yamashita A. Synergistic effect of lentinan and surgical endocrine th erapy of the growth of DMBA-induced mammary tumours of rats and of recurrent human breast cancer. Exc Med Int Conf 1985, 690, 138-199.
20. Sarosdy MF, Lowe BA, Schellhammer PG, et al. Bropiramine immunotherapy of bladder CIS: positive phase II results of an oral interferon inducer. Proc Am Soc Clin Oncol 1994, Dallas, 719.